The invention relates to methods and reagents for promoting the differentiation of oligodendrocytes from stem cells, by co-activating the Olig genes and the Nkx2.2 genes, and the use of the differentiated oligodendrocytes thus obtained in treating diseases, such as Multiple Sclerosis (MS). The invention also relates to the use of OLPs and oligodendrocytes thus obtained for drug screening.

 
Web www.patentalert.com

< Heteroaryl (substituted)alkyl N-substituted sulfoximines as insecticides

< Isolation and use of solid tumor stem cells

> Methods for altering cell fate

> Carboxylic acid peri-substituted bicyclics for occlusive artery disease
~ 00615